NewsRx

Search our medical news database

Conference News

Engineered Antibodies Accelerating Drug Discovery And Development Conference Rescheduled

Published in Vaccine Weekly, October 24th, 2001

The world antibodies research community will be convening in Philadelphia, Pennsylvania, on October 22-23, 2001, to attend, speak, and exhibit at "Engineered Antibodies Accelerating Drug Discovery and Development" conference which was rescheduled after the events of September 11, 2001, announced Strategic Research Institute.

The conference and exposition was originally scheduled for September 18-19, 2001. The quality and integrity of the agenda has been preserved with several new additions. To request the agenda, please contact Ed Drilon at edrilon@srinstitute.com.

The conference, focusing on industrial applications in the pharmaceutical industry,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook